Compare DexCom, Inc. (DXCM) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Quantumscape Corp — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Quantumscape Corp trades at $6.39 (market cap $3.90B). The key difference: DexCom, Inc. is far larger — about 8.7× Quantumscape Corp's market cap, and DexCom, Inc. is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| DXCM | QS | |
|---|---|---|
Market Cap | $33.79B | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $18.44 |
52-Week Low | $54.84 | $4.89 |
Enterprise Value | $33.24B | $3.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
